{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:31Z","timestamp":1791919051563,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University Jena"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12031-015-0681-8","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T07:40:35Z","timestamp":1447314035000},"page":"343-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy"],"prefix":"10.1007","volume":"58","author":[{"given":"Aria","family":"Baniahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"681_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00441-012-1377-9","volume":"1","author":"H Banno","year":"2012","unstructured":"Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G (2012) Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Cell Tissue Res 1:313\u2013320","journal-title":"Cell Tissue Res"},{"issue":"2","key":"681_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.149.2.255","volume":"149","author":"M Becker","year":"2000","unstructured":"Becker M, Martin E, Schneikert J, Krug HF, Cato AC (2000) Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol 149(2):255\u2013262","journal-title":"J Cell Biol"},{"issue":"16","key":"681_CR3","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/00001756-200211150-00025","volume":"13","author":"RS Darrington","year":"2002","unstructured":"Darrington RS, Butler R, Leigh PN, McPhaul MJ, Gallo JM (2002) Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells. Neuroreport 13(16):2117\u20132120","journal-title":"Neuroreport"},{"issue":"4","key":"681_CR4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/mend.16.4.0798","volume":"16","author":"H Dotzlaw","year":"2002","unstructured":"Dotzlaw H, Moehren U, Mink S, Cato AC, I\u00f1iguez Lluh\u00ed JA, Baniahmad A (2002) The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol Endocrinol 16(4):661\u2013673","journal-title":"Mol Endocrinol"},{"issue":"1","key":"681_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2003.10.036","volume":"213","author":"H Dotzlaw","year":"2003","unstructured":"Dotzlaw H, Papaioannou M, Moehren U, Claessens F, Baniahmad A (2003) Agonist\u2013antagonist induced coactivator and corepressor interplay on the human androgen receptor. Mol Cell Endocrinol 213(1):79\u201385","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"681_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10(2):140\u2013147","journal-title":"Lancet Neurol"},{"issue":"19","key":"681_CR7","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1016\/j.bmc.2010.08.029","volume":"18","author":"MA Fousteris","year":"2010","unstructured":"Fousteris MA, Schubert U, Roell D, Roediger J, Bailis N, Nikolaropoulos SS, Baniahmad A, Giannis A (2010) 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth. Bioorg Med Chem 18(19):6960\u20136969","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"681_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/hmg\/ddu419","volume":"24","author":"E Giorgetti","year":"2015","unstructured":"Giorgetti E, Rusmini P, Crippa V, Cristofani R, Boncoraglio A, Cicardi ME, Galbiati M, Poletti A (2015) Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum Mol Genet 24(1):64\u201375","journal-title":"Hum Mol Genet"},{"issue":"4","key":"681_CR9","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-13-0545","volume":"21","author":"C Helsen","year":"2014","unstructured":"Helsen C, Van den Broeck T, Voet A, Prekovic S, Van Poppel H, Joniau S, Claessens F (2014) Androgen receptor antagonists for prostate cancer therapy. Endocr Relat Cancer 21(4):T105\u2013T118","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"681_CR10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1210\/me.2014-1170","volume":"28","author":"W Hessenkemper","year":"2014","unstructured":"Hessenkemper W, Roediger J, Bartsch S, Houtsmuller AB, van Royen ME, Petersen I, Grimm M-O, Baniahmad A (2014) A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells. Mol Endocrinol 28(11):1831\u20131840","journal-title":"Mol Endocrinol"},{"issue":"17","key":"681_CR11","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-07-0617","volume":"67","author":"MC Hodgson","year":"2007","unstructured":"Hodgson MC, Astapova I, Hollenberg AN, Balk SP (2007) Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res 67(17):8388\u20138395","journal-title":"Cancer Res"},{"issue":"6","key":"681_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbadis.2012.02.006","volume":"1822","author":"T Jochum","year":"2012","unstructured":"Jochum T, Ritz ME, Schuster C, Funderburk SF, Jehle K, Schmitz K, Brinkmann F, Hirtz M, Moss D, Cato AC (2012) Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures. Biochim Biophys Acta 1822(6):1070\u20131078","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"681_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000313682","volume":"8","author":"JA Johansen","year":"2011","unstructured":"Johansen JA, Troxell-Smith SM, Yu Z, Mo K, Monks DA, Lieberman AP, Breedlove SM, Jordan CL (2011) Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy. Neurodegener Dis 8(1\u20132):25\u201334","journal-title":"Neurodegener Dis"},{"key":"681_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/978-1-4419-6448-9_6","volume":"685","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G (2010) Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). Adv Exp Med Biol 685:64\u201374","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"681_CR15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","volume":"99","author":"M Katsuno","year":"2012","unstructured":"Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G (2012) Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog Neurobiol 99(3):246\u2013256","journal-title":"Prog Neurobiol"},{"issue":"1","key":"681_CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jnnp.2006.101899","volume":"79","author":"P Kinirons","year":"2008","unstructured":"Kinirons P, Rouleau GA (2008) Administration of testosterone results in reversible deterioration in Kennedy\u2019s disease. J Neurol Neurosurg Psychiatry 79(1):106\u2013107","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"681_CR17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/hmg\/ddp115","volume":"18","author":"HL Montie","year":"2009","unstructured":"Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE (2009) Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 18(11):1937\u20131950","journal-title":"Hum Mol Genet"},{"issue":"6","key":"681_CR18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP (2010) Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67(6):936\u2013952","journal-title":"Neuron"},{"issue":"46","key":"681_CR19","doi-asserted-by":"crossref","first-page":"35567","DOI":"10.1074\/jbc.M110.146845","volume":"285","author":"CR Orr","year":"2010","unstructured":"Orr CR, Montie HL, Liu Y, Bolzoni E, Jenkins SC, Wilson EM, Joseph JD, McDonnell DP, Merry DE (2010) An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem 285(46):35567\u201335577","journal-title":"J Biol Chem"},{"issue":"8B","key":"681_CR20","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/j.1582-4934.2008.00426.x","volume":"13","author":"M Papaioannou","year":"2009","unstructured":"Papaioannou M, Schleich S, Prade I, Degen S, Roell D, Schubert U, Tanner T, Claessens F, Matusch R, Baniahmad A (2009) The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth. J Cell Mol Med 13(8B):2210\u20132223","journal-title":"J Cell Mol Med"},{"issue":"4","key":"681_CR21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.yfrne.2011.06.003","volume":"32","author":"S Parodi","year":"2011","unstructured":"Parodi S, Pennuto M (2011) Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Front Neuroendocrinol 32(4):416\u2013425","journal-title":"Front Neuroendocrinol"},{"key":"681_CR22","doi-asserted-by":"crossref","unstructured":"Perner S, Cronauer MV, Schrader AJ, Klocker H, Culig Z, Baniahmad A (2015) Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer. Oncotarget, in press.","DOI":"10.18632\/oncotarget.4689"},{"issue":"7","key":"681_CR23","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1210\/en.2013-1756","volume":"155","author":"KJ Renier","year":"2014","unstructured":"Renier KJ, Troxell-Smith SM, Johansen JA, Katsuno M, Adachi H, Sobue G, Chua JP, Sun Kim H, Lieberman AP, Breedlove SM, Jordan CL (2014) Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy. Endocrinology 155(7):2624\u20132634","journal-title":"Endocrinology"},{"issue":"3","key":"681_CR24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12031-013-9978-7","volume":"50","author":"A Rocchi","year":"2013","unstructured":"Rocchi A, Pennuto M (2013) New routes to therapy for spinal and bulbar muscular atrophy. J Mol Neurosci 50(3):514\u2013523","journal-title":"J Mol Neurosci"},{"issue":"1\u20132","key":"681_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2010.09.013","volume":"332","author":"D Roell","year":"2011","unstructured":"Roell D, Baniahmad A (2011) The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth. Mol Cell Endocrinol 332(1\u20132):1\u20138","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"681_CR26","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2013.05.026","volume":"34","author":"P Rusmini","year":"2013","unstructured":"Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, Carra S, Poletti A (2013) Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging 34(11):2585\u20132603","journal-title":"Neurobiol Aging"},{"issue":"8","key":"681_CR27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/jnnp.2003.030064","volume":"75","author":"T Shimohata","year":"2004","unstructured":"Shimohata T, Kimura T, Nishizawa M, Onodera O, Tsuji S (2004) Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin. J Neurol Neurosurg Psychiatry 75(8):1206\u20131207","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"681_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/hmg\/9.1.133","volume":"9","author":"S Simeoni","year":"2000","unstructured":"Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A (2000) Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9(1):133\u2013144","journal-title":"Hum Mol Genet"},{"issue":"5","key":"681_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/hmg\/8.5.731","volume":"8","author":"DL Stenoien","year":"1999","unstructured":"Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8(5):731\u2013741","journal-title":"Hum Mol Genet"},{"key":"681_CR30","unstructured":"Tan ME, Li J, Xu HE, Melcher K, Yong EL (2014) Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 1\u201321"},{"key":"681_CR31","doi-asserted-by":"crossref","first-page":"369284","DOI":"10.1155\/2012\/369284","volume":"2012","author":"F Tanaka","year":"2012","unstructured":"Tanaka F, Katsuno M, Banno H, Suzuki K, Adachi H, Sobue G (2012) Current status of treatment of spinal and bulbar muscular atrophy. Neural Plast 2012:369284","journal-title":"Neural Plast"},{"issue":"5928","key":"681_CR32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","volume":"324","author":"C Tran","year":"2009","unstructured":"Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL (2009) Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 324(5928):787\u2013790","journal-title":"Science"},{"key":"681_CR33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/me.2005-0324","volume":"20","author":"HG Yoon","year":"2006","unstructured":"Yoon HG, Wong J (2006) The corepressors silencing mediator of retinoid and thyroid hormone receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol Endocrinol 20:1048\u20131060","journal-title":"Mol Endocrinol"},{"issue":"10","key":"681_CR34","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116(10):2663\u20132672","journal-title":"J Clin Invest"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-015-0681-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0681-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T13:17:39Z","timestamp":1567343859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-015-0681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1007\/s12031-015-0681-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}